Innovation AveNEW is a program designed for start-up or emerging companies in the life sciences and technologies space. This specially designated area of the exhibition will connect you to purchasing influencers and decision-makers from around the world — at no cost. Companies selected for Innovation AveNEW are given the opportunity to elevate the promotion of their new company, product or service. Innovation AveNEW companies pay no fees and are rewarded with access to a global audience and business consulting, and can opt-in to compete for the SLAS Ignite Award. Innovation AveNEW applications are accepted year-round for the International Conference & Exhibition and the Europe Conference & Exhibition.
Innovation AveNEW companies who opt-in to compete for the SLAS Ignite Award will be judged by an SLAS panel on a combination of key concepts, including their marketing plan, market presence and potential; funding prospects; plan for growth and the existence of balanced company leadership, among other qualities, for a chance to win $5,000.
Congratulations to the companies selected to participate in Innovation AveNEW at SLAS2022!
A4CELL Nanodevices (Spain)
AlveoliX AG (Switzerland)
BennuBio, Inc. (United States)
BBD BioPhenix USA LLC - Biobide USA (Spain/United States)
Biomedica Molecular Medicine (Spain)
Celldynamics ISRL (Italy)
Celtarys Research (Spain)
DIVERSA Technologies (Spain)
Erebagen (United Kingdom)
HexagonFab (United Kingdom)
Iktos (United States)
Kebotix (United States)
LabVoice (United States)
Magnitude Biosciences, Ltd. (United Kingdom)
Mcule (Hungary)
Partillion Bioscience (United States)
Scintillation Nanotechnologies, Inc. (United States)